779 related articles for article (PubMed ID: 10212103)
1. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
[TBL] [Abstract][Full Text] [Related]
3. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma.
Jatakanon A; Kharitonov S; Lim S; Barnes PJ
Thorax; 1999 Feb; 54(2):108-14. PubMed ID: 10325913
[TBL] [Abstract][Full Text] [Related]
4. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
Jatakanon A; Lim S; Kharitonov SA; Chung KF; Barnes PJ
Thorax; 1998 Feb; 53(2):91-5. PubMed ID: 9624291
[TBL] [Abstract][Full Text] [Related]
5. An inhaled steroid improves markers of airway inflammation in patients with mild asthma.
Jatakanon A; Lim S; Chung KF; Barnes PJ
Eur Respir J; 1998 Nov; 12(5):1084-8. PubMed ID: 9864001
[TBL] [Abstract][Full Text] [Related]
6. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
7. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma.
Chalmers GW; Macleod KJ; Little SA; Thomson LJ; McSharry CP; Thomson NC
Thorax; 2002 Mar; 57(3):226-30. PubMed ID: 11867826
[TBL] [Abstract][Full Text] [Related]
8. Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics.
Dal Negro R; Micheletto C; Tognella S; Turco P; Rossetti A; Cantini L
Allergy; 2003 Oct; 58(10):1018-22. PubMed ID: 14510719
[TBL] [Abstract][Full Text] [Related]
9. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
Fardon TC; Lee DK; Hodge MR; Lipworth BJ
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):259-65. PubMed ID: 16200817
[TBL] [Abstract][Full Text] [Related]
10. Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
Eur Respir J; 2002 Oct; 20(4):853-8. PubMed ID: 12412675
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils.
Gauvreau GM; Inman MD; Kelly M; Watson RM; Dorman SC; O'Byrne PM
Can Respir J; 2002; 9(1):26-32. PubMed ID: 11856987
[TBL] [Abstract][Full Text] [Related]
12. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship.
Jones SL; Herbison P; Cowan JO; Flannery EM; Hancox RJ; McLachlan CR; Taylor DR
Eur Respir J; 2002 Sep; 20(3):601-8. PubMed ID: 12358335
[TBL] [Abstract][Full Text] [Related]
13. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
14. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
[TBL] [Abstract][Full Text] [Related]
15. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
[TBL] [Abstract][Full Text] [Related]
16. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation.
Loppow D; Schleiss MB; Kanniess F; Taube C; Jörres RA; Magnussen H
Respir Med; 2001 Feb; 95(2):115-21. PubMed ID: 11217907
[TBL] [Abstract][Full Text] [Related]
17. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
[TBL] [Abstract][Full Text] [Related]
18. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma.
Faul JL; Demers EA; Burke CM; Poulter LW
Chest; 2002 May; 121(5):1414-20. PubMed ID: 12006422
[TBL] [Abstract][Full Text] [Related]
19. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre.
Ichinose M; Takahashi T; Sugiura H; Endoh N; Miura M; Mashito Y; Shirato K
Eur Respir J; 2000 Feb; 15(2):248-53. PubMed ID: 10706487
[TBL] [Abstract][Full Text] [Related]
20. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.
Nocker RE; Out TA; Weller FR; de Riemer MJ; Jansen HM; van der Zee JS
J Lab Clin Med; 2000 Jul; 136(1):39-49. PubMed ID: 10882226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
